A detailed history of Ardent Capital Management, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Ardent Capital Management, Inc. holds 146,859 shares of JNJ stock, worth $22.7 Million. This represents 10.87% of its overall portfolio holdings.

Number of Shares
146,859
Previous 152,503 3.7%
Holding current value
$22.7 Million
Previous $22.3 Million 6.77%
% of portfolio
10.87%
Previous 10.97%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$145.48 - $167.38 $821,089 - $944,692
-5,644 Reduced 3.7%
146,859 $23.8 Million
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $432,851 - $473,024
2,998 Added 2.01%
152,503 $22.3 Million
Q1 2024

May 07, 2024

BUY
$155.22 - $162.74 $87,854 - $92,110
566 Added 0.38%
149,505 $23.7 Million
Q4 2023

Feb 08, 2024

BUY
$145.6 - $158.88 $145,600 - $158,880
1,000 Added 0.68%
148,939 $23.3 Million
Q3 2023

Nov 06, 2023

BUY
$155.75 - $174.48 $1.19 Million - $1.33 Million
7,649 Added 5.45%
147,939 $23 Million
Q2 2023

Aug 14, 2023

BUY
$154.35 - $166.11 $965,304 - $1.04 Million
6,254 Added 4.67%
140,290 $23.2 Million
Q1 2023

May 12, 2023

BUY
$151.05 - $180.26 $409,194 - $488,324
2,709 Added 2.06%
134,036 $20.8 Million
Q4 2022

Feb 14, 2023

BUY
$160.2 - $179.79 $19,864 - $22,293
124 Added 0.09%
131,327 $23.2 Million
Q3 2022

Feb 01, 2023

BUY
$161.33 - $179.52 $233,444 - $259,765
1,447 Added 1.12%
131,203 $21.4 Million
Q2 2022

Aug 08, 2022

BUY
$168.19 - $186.01 $8,241 - $9,114
49 Added 0.04%
129,756 $23 Million
Q1 2022

May 16, 2022

SELL
$158.14 - $179.59 $489,443 - $555,831
-3,095 Reduced 2.33%
129,707 $23 Million
Q4 2021

Jan 20, 2022

BUY
$155.93 - $173.01 $20.7 Million - $23 Million
132,802 New
132,802 $22.7 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $404B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Ardent Capital Management, Inc. Portfolio

Follow Ardent Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ardent Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ardent Capital Management, Inc. with notifications on news.